IP Library Granted Patent US 8,580,518
Granted Patent B2
US 8,580,518 · App. 12/467,808 · Granted Nov 12, 2013

Methods, devices, kits and compositions for detecting roundworm

Inventors: David Allen Elsemore (South Portland, ME); Laurie A. Flynn (Raymond, ME); Jinming Geng (Scarborough, ME); Michael Crawford (St. Louis, MO)
Assignees: IDEXX Laboratories, Inc.; Divergence, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,580,518
App. No.
12/467,808
Granted
Nov 12, 2013
Kind
B2
Abstract

Methods, devices, kits and compositions for detecting the presence or absence of roundworm in a fecal sample are disclosed herein. The methods, devices, kits and compositions of the present invention may be used to confirm the presence or absence of roundworm in a fecal sample from a mammal that may also be infected with one or more of hookworm, whipworm, and heartworm. Confirmation of the presence or absence of roundworm in the mammal may be made, for example, for the purpose of selecting an optimal course of treating the mammal and/or for the purpose of determining whether the mammal has been rid of the infection after treatment has been initiated.

Claims (22)

1. A method of detecting the presence or absence of one or more roundworm antigens in a sample, the method comprising the steps of:

(a) contacting a sample from a mammal with one or more antibodies that specifically bind to a polypeptide consisting of the amino acid sequence SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO: 11, or Copro6728;

(b) forming antibody-polypeptide complexes in the presence of the polypeptides if any, in the sample; and

(c) detecting the presence or absence of the antibody-polypeptide complexes, if any.

2. A method of diagnosing whether a mammal is infected with an intestinal roundworm infection, the method comprising the steps of:

(a) contacting a sample from a mammal with one or more antibodies that specifically bind to a polypeptide consisting of the amino acid sequence SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO: 11, or Copro6728;

(b) forming antibody-polypeptide complexes in the presence of the polypeptides, if any, in the sample;

(c) detecting the presence or absence of the antibody-polypeptide complexes, if any; and

(d) diagnosing the mammal as having the roundworm infection if a roundworm antibody-polypeptide complex is present.

3. The method of any of claim 1 or 2 , further comprising the step of contacting the sample with one or more reagents to detect one or more of the group consisting of: one or more non-roundworm worm parasites, one or more non-worm parasites, one or more viruses, one or more fungi, and one or more bacteria.

4. The method of claim 3 , wherein the reagents for the detection of any one or all of the one or more non-roundworm worm parasites, one or more non-worm parasites, one or more viruses, one or more fungi and the one or more bacteria are one or more antibodies or one or more antigens recognized by antibodies specific for one or more non-roundworm worm parasites, one or more non-worm parasites, one or more viruses, one or more fungi or one or more bacteria.

5. The method of any of claim 1 or 2 , wherein the one or more roundworm antigens are the polypeptide having amino acid sequence that corresponds to SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO: 11, or Copro6728.

6. The method of any of claim 1 or 2 , wherein the sample is obtained from a mammal that is a canine or a feline.

7. The method of claim 6 , wherein the roundworm is Toxocara canis or Toxocara cati.

8. The method of any of claim 1 or 2 , wherein the sample is a fecal sample.

9. The method of claim 8 , wherein the one or more antibodies do not specifically bind any coproantigen derived from the group consisting of hookworm, whipworm, and heartworm.

10. The method of any of claim 1 or 2 , wherein the step of detecting the presence or absence of the complexes further includes the step of providing at least one secondary antibody that binds to at least one of the complexes.

11. The method of claim 10 , wherein the at least one secondary antibody is labeled.

12. The method of any of claim 1 or 2 , wherein one or more of the one or more antibodies are labeled.

13. The method of any of claim 1 or 2 , wherein the one or more antibodies are immobilized on a solid support.

14. The method of claim 13 , wherein the solid support forms part of an enzyme-linked immunosorbent assay device.

15. The method of claim 14 , wherein the enzyme-linked immunosorbent assay device is a lateral flow immunoassay device.

Assignments (3)
MERGER Recorded Dec 5, 2018
From: DIVERGENCE, INC.
To: MONSANTO COMPANY
Reel/Frame 047680/0006 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2013
From: ELSEMORE, DAVID ALLEN; FLYNN, LAURIE A.; GENG, JINMING
To: IDEXX LABORATORIES, INC.
Reel/Frame 031331/0153 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2013
From: CRAWFORD, MICHAEL
To: DIVERGENCE, INC.
Reel/Frame 031331/0172 →
Continuity (2)
Provisional Application 61128099 · May 19, 2008
Related Publication 20090286229A1 · Nov 19, 2009